Correlation Between ACELYRIN, INC and Gracell Biotechnologies
Can any of the company-specific risk be diversified away by investing in both ACELYRIN, INC and Gracell Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACELYRIN, INC and Gracell Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ACELYRIN, INC Common and Gracell Biotechnologies, you can compare the effects of market volatilities on ACELYRIN, INC and Gracell Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACELYRIN, INC with a short position of Gracell Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACELYRIN, INC and Gracell Biotechnologies.
Diversification Opportunities for ACELYRIN, INC and Gracell Biotechnologies
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ACELYRIN, and Gracell is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding ACELYRIN, INC Common and Gracell Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gracell Biotechnologies and ACELYRIN, INC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACELYRIN, INC Common are associated (or correlated) with Gracell Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gracell Biotechnologies has no effect on the direction of ACELYRIN, INC i.e., ACELYRIN, INC and Gracell Biotechnologies go up and down completely randomly.
Pair Corralation between ACELYRIN, INC and Gracell Biotechnologies
If you would invest 457.00 in ACELYRIN, INC Common on September 2, 2024 and sell it today you would lose (2.00) from holding ACELYRIN, INC Common or give up 0.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.56% |
Values | Daily Returns |
ACELYRIN, INC Common vs. Gracell Biotechnologies
Performance |
Timeline |
ACELYRIN, INC Common |
Gracell Biotechnologies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ACELYRIN, INC and Gracell Biotechnologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ACELYRIN, INC and Gracell Biotechnologies
The main advantage of trading using opposite ACELYRIN, INC and Gracell Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACELYRIN, INC position performs unexpectedly, Gracell Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gracell Biotechnologies will offset losses from the drop in Gracell Biotechnologies' long position.ACELYRIN, INC vs. Tff Pharmaceuticals | ACELYRIN, INC vs. Eliem Therapeutics | ACELYRIN, INC vs. Inhibrx | ACELYRIN, INC vs. Enliven Therapeutics |
Gracell Biotechnologies vs. Monte Rosa Therapeutics | Gracell Biotechnologies vs. Design Therapeutics | Gracell Biotechnologies vs. Erasca Inc | Gracell Biotechnologies vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |